22:22 29/08/2016 Pfizer Inc. (PFE) Closes 0.83% Up on the Day for August 29
Pfizer Inc. (PFE) Closes 0.83% Up on the Day for August 29
Equities.com - 19 hours ago
Pfizer Inc. currently has a total float of 6.07 billion shares and moves 19.3 million a day, on average. The stock opened at $34.94 on August 29 and traded between a low of $34.82 and a high of $35.17.

16:22 29/08/2016 In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated
In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated
Benzinga - Aug 29, 2016
On August 22, Pfizer Inc. (NYSE: PFE) announced it had entered into an agreement to acquire Medivation Inc (NASDAQ: MDVN) for almost $14 billion or $81.50 per shares.
Why Pfizer Inc Stock Looks Set For A Good Run In 2016 - Amigobulls
What's the Story behind the Pfizer-Medivation Deal? - Market Realist

15:32 29/08/2016 Pfizer Inc. (PFE) Stock: One Of The Best Picks In The Pharma Industry
Pfizer Inc. (PFE) Stock: One Of The Best Picks In The Pharma Industry
TCC - Aug 29, 2016
Pfizer Inc. (NYSE:PFE) is one of the finest picks in the pharma industry, but has rather been negated by investors lately. Since the start of this month, stock prices have been following a downward trend.
Notable Stock Analyst Ratings: KeyCorp (NYSE:KEY), Pfizer Inc. (NYSE:PFE) - Review Fortune
DNB Asset Management AS Has $97803000 Stake in Pfizer Inc. (PFE) - Community Financial News

13:33 29/08/2016 Research Report for: Pfizer, Inc. (NYSE:PFE)
Research Report for: Pfizer, Inc. (NYSE:PFE)
News Oracle - Aug 29, 2016
Pfizer, Inc. (NYSE:PFE) reported its last earnings on Aug 02 BMO (BMO = before market open, AMC= after market close).
Important Analyst Opinions about Stock's Earnings: Pfizer, Inc. (NYSE:PFE ... - Is stories

19:00 26/08/2016 Pfizer Inc. (NYSE:PFE) at $34.77: How much higher it can go
Pfizer Inc. (NYSE:PFE) at $34.77: How much higher it can go
Review Fortune - Aug 26, 2016
Pfizer Inc. (NYSE:PFE) down -1.19% for the past 5 days, is under coverage of 22 analysts who collectively assign a hold rating on stock.

18:26 26/08/2016 SunTrust Banks Comments on Pfizer Inc.'s Q4 2016 Earnings (PFE)
SunTrust Banks Comments on Pfizer Inc.'s Q4 2016 Earnings (PFE)
The Cerbat Gem - Aug 26, 2016
Pfizer logo Pfizer Inc. (NYSE:PFE) - Stock analysts at SunTrust Banks dropped their Q4 2016 earnings per share (EPS) estimates for Pfizer in a research report issued on Wednesday.
Pfizer Inc. (NYSE:PFE) Buys BIND's Assets - LearnBonds
Pfizer Inc.: This Tiny Biotech Stock Has WAY More Upside Than PFE Stock - Profit Confidential

13:45 26/08/2016 what are Analysts report about: Pfizer, Inc. (NYSE:PFE)
what are Analysts report about: Pfizer, Inc. (NYSE:PFE)
News Oracle - Aug 26, 2016
Pfizer, Inc. (NYSE:PFE) reported its last earnings on Aug 02 BMO (BMO = before market open, AMC= after market close).
Institutional Investors Have Decreased Positions in Pfizer Inc. (NYSE:PFE) - Engelwood Daily

11:08 26/08/2016 Pfizer's Involvement in EpiPens Could Complicate Drug Price Debate
Pfizer's Involvement in EpiPens Could Complicate Drug Price Debate
Morning Consult - Aug 26, 2016
Mylan Pharmaceuticals has come under intense fire for massive price hikes of EpiPens over the last week, facing scrutiny from lawmakers and industry groups.
How Mylan And Pfizer Could Cause A Major Biotech Backlash - Forbes

7:25 24/08/2016 Pfizer to Buy Antibiotics From AstraZeneca for $725 Million
Pfizer to Buy Antibiotics From AstraZeneca for $725 Million
Bloomberg - Aug 24, 2016
Pfizer Inc. agreed to buy an antibiotics business from AstraZeneca Plc for $725 million as well as other payouts, settling for one piece of a company it once tried to acquire.
Pfizer to buy rival's antibiotics rights - Press Herald
Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre ... - Benzinga

15:44 23/08/2016 Pfizer Inc.: Medivation Acquisition Could Send Pfizer Stock Soaring
Pfizer Inc.: Medivation Acquisition Could Send Pfizer Stock Soaring
Profit Confidential - Aug 23, 2016
Pfizer Inc. (NYSE:PFE), the pharmaceutical giant behind such elevated brands as “Viagra,” has made a successful bid for Medivation Inc (NASDAQ:MDVN) with an offer of $14.0 billion.
Pfizer boosts cancer drug roster with $14 billion Medivation deal - Reuters